Simultaneous quantitation of serum HBV DNA and HBeAg can distinguish between slow and fast viral responses to antiviral therapy in patients with chronic hepatitis B A quantificação simultânea do DNA VHB e do AgHBe séricos podem distinguir entre resposta viral lenta e rápida à terapêutica anti-viral em pacientes com hepatite crônica B

• Published in: Revista do Instituto de Medicina Tropical de São Paulo
• Main Authors: Luiz Caetano da Silva, Maria Luiza da Nova, Suzane Kioko Ono-Nita, João Renato Rebello Pinho, Roberta Sitnik, Vera Aparecida dos Santos, Flair José Carrilho
• Format: Article in Journal/Newspaper
• Language: English
• Published: Universidade de São Paulo (USP) 2009
• Subjects: Hepatitis B; Serological markers; Treatment response; Treatment follow-up; Arctic medicine. Tropical medicine; RC955-962; Infectious and parasitic diseases; RC109-216; Arctic; Sob’
• Online Access: https://doi.org/10.1590/S0036-46652009000500005; https://doaj.org/article/ed27dde5acba4238a211b6e11337d1d8

BACKGROUND: The quantitation of serum HBeAg is not commonly used to monitor viral response to therapy in chronic hepatitis B. METHODS: In this study, 21 patients receiving varying therapies were followed and their viral response monitored by concomitant viral load and HBeAg quantitation in order to...